These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34326654)

  • 41. Curcumin Prevents Neuroinflammation by Inducing Microglia to Transform into the M2-phenotype via CaMKKβ-dependent Activation of the AMP-Activated Protein Kinase Signal Pathway.
    Qiao P; Ma J; Wang Y; Huang Z; Zou Q; Cai Z; Tang Y
    Curr Alzheimer Res; 2020; 17(8):735-752. PubMed ID: 33176649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FTY720 Inhibits MPP
    Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Demethylenetetrahydroberberine protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Wen J; Zhang YQ; Liu DQ; Yao XT; Jiang H; Zhang YB
    Chin J Nat Med; 2022 Feb; 20(2):111-119. PubMed ID: 35279238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopamine Receptor D3 Expression Is Altered in CD4
    Elgueta D; Contreras F; Prado C; Montoya A; Ugalde V; Chovar O; Villagra R; Henríquez C; Abellanas MA; Aymerich MS; Franco R; Pacheco R
    Front Immunol; 2019; 10():981. PubMed ID: 31118938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dl-3-
    Chen Y; Wu T; Li H; Li X; Li Q; Zhu X; Yu M; Kuo SH; Huang F; Wu YC
    Front Aging Neurosci; 2019; 11():44. PubMed ID: 30873019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RIPK1 Regulates Microglial Activation in Lipopolysaccharide-Induced Neuroinflammation and MPTP-Induced Parkinson's Disease Mouse Models.
    Kim DY; Leem YH; Park JS; Park JE; Park JM; Kang JL; Kim HS
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Depression Induced by Chronic Unpredictable Mild Stress Increases Susceptibility to Parkinson's Disease in Mice via Neuroinflammation Mediated by P2X7 Receptor.
    Ren C; Li LX; Dong AQ; Zhang YT; Hu H; Mao CJ; Wang F; Liu CF
    ACS Chem Neurosci; 2021 Apr; 12(7):1262-1272. PubMed ID: 33734697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease.
    Bao LH; Zhang YN; Zhang JN; Gu L; Yang HM; Huang YY; Xia N; Zhang H
    J Neuroinflammation; 2018 May; 15(1):131. PubMed ID: 29720230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
    Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
    Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human Amniotic Epithelial Cells Alleviate a Mouse Model of Parkinson's Disease Mainly by Neuroprotective, Anti-Oxidative and Anti-Inflammatory Factors.
    Zhang J; Li H; Yang H; Lin J; Wang Y; Zhang Q; Gao WQ; Xu H
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):620-633. PubMed ID: 33164162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HSF1 inhibits microglia activation to attenuate neuroinflammation via regulating miR-214-3p and NFATc2 in Parkinson's disease.
    Liao Y; Gu Y; Wang J; Tian Y; Ni X; Zhou L; Ye Y; Xia G
    Folia Neuropathol; 2023; 61(1):53-67. PubMed ID: 37114961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway.
    Jing H; Wang S; Wang M; Fu W; Zhang C; Xu D
    PLoS One; 2017; 12(1):e0169560. PubMed ID: 28060896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinson's disease mouse model: Endothelial and microglial effects.
    Burks S; Raymick J; Robinson B; Hanig J; Sarkar S
    Neurosci Lett; 2019 Jun; 703():86-95. PubMed ID: 30890473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson's disease.
    Qin Y; Qiu J; Wang P; Liu J; Zhao Y; Jiang F; Lou H
    Brain Behav Immun; 2021 Jan; 91():324-338. PubMed ID: 33039664
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treadmill exercise alleviates neuronal damage by suppressing NLRP3 inflammasome and microglial activation in the MPTP mouse model of Parkinson's disease.
    Wang W; Lv Z; Gao J; Liu M; Wang Y; Tang C; Xiang J
    Brain Res Bull; 2021 Sep; 174():349-358. PubMed ID: 34224819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 2-Hydroxy-4-Methylbenzoic Anhydride Inhibits Neuroinflammation in Cellular and Experimental Animal Models of Parkinson's Disease.
    Song SY; Kim IS; Koppula S; Park JY; Kim BW; Yoon SH; Choi DK
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33147699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.
    Subramaniam SR; Federoff HJ
    Front Aging Neurosci; 2017; 9():176. PubMed ID: 28642697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson's disease.
    Ren M; Guo Y; Wei X; Yan S; Qin Y; Zhang X; Jiang F; Lou H
    Exp Neurol; 2018 Apr; 302():205-213. PubMed ID: 29407460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Levodopa partially rescues microglial numerical, morphological, and phagolysosomal alterations in a monkey model of Parkinson's disease.
    Lecours C; St-Pierre MK; Picard K; Bordeleau M; Bourque M; Awogbindin IO; Benadjal A; Ibanez FG; Gagnon D; Cantin L; Parent M; Di Paolo T; Tremblay ME
    Brain Behav Immun; 2020 Nov; 90():81-96. PubMed ID: 32755645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.